Even modest previous cannabis use blunted THC's effects on psychosis symptoms and brain function
In a THC challenge study, abstinent modest cannabis users showed worse baseline cognition but more blunted psychotomimetic and neurophysiological responses to acute THC compared to never-users.
Quick Facts
What This Study Found
Using the same 24-participant THC challenge design, this companion study focused on cognitive processing and psychotomimetic effects. Compared to never-users, abstinent modest cannabis users showed a complex profile of both residual effects and acquired tolerance.
At baseline (under placebo), modest users showed worse cognitive performance and stronger right-hemisphere brain activation during cognitive tasks. These residual effects persisted despite abstinence, suggesting lasting neural changes from even modest cannabis exposure.
However, when both groups received THC, a reversal appeared. Acute THC produced greater psychotomimetic symptoms in never-users than in modest users. In never-users, the severity of THC-induced psychotic symptoms and cognitive impairment correlated directly with the degree of brain activity disruption, a relationship not seen in modest users.
The brain activity patterns revealed three distinct states: normal processing (never-users under placebo), acutely disrupted processing (never-users under THC), and an intermediate state seen in modest users that showed features of both adaptation and residual change.
Key Numbers
24 healthy men. Modest users had worse cognitive performance under placebo (p < 0.047). Greater right-hemisphere activation in modest users during cognitive processing. Psychotomimetic symptoms greater in non-users under THC (p = 0.040). Brain activity pattern: intermediate state in modest users under THC.
How They Did This
Double-blind, randomized, placebo-controlled, repeated-measures, within-subject crossover study with fMRI. Twenty-four healthy men: 12 non-users and 12 abstinent modest users. Cognitive processing, psychotomimetic symptoms, and brain activation patterns were measured under both THC and placebo conditions.
Why This Research Matters
This study reveals a paradox of modest cannabis use: it creates residual cognitive changes but also builds tolerance that buffers against the most dramatic acute effects of THC. This helps explain the clinical observation that cannabis-naive individuals are most at risk for acute psychotic reactions to cannabis.
The Bigger Picture
Together with the companion study on emotional processing, these findings paint a nuanced picture: modest cannabis use creates lasting brain changes (residual effects) while simultaneously building tolerance to acute THC effects. This dual nature of cannabis neuroadaptation has important implications for risk assessment and public health messaging.
What This Study Doesn't Tell Us
Small sample of 24 male participants. The modest user group was defined by approximately 25 lifetime uses, an arbitrary threshold. Cannot separate true tolerance from pre-existing differences. Cross-sectional design limits causal conclusions. Only cognitive and psychotic symptom domains were assessed.
Questions This Raises
- ?Is the acquired tolerance to THC's psychotomimetic effects protective or does it encourage further use?
- ?Do the residual cognitive effects observed under placebo have functional consequences in daily life?
- ?Would the tolerance pattern differ with higher levels of prior cannabis exposure?
Trust & Context
- Key Stat:
- Modest users showed worse baseline cognition but blunted psychotic response to THC
- Evidence Grade:
- This is a well-designed crossover study with neuroimaging, limited by small sample size and cross-sectional comparison.
- Study Age:
- Published in 2018. Understanding of cannabis tolerance mechanisms continues to develop.
- Original Title:
- Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
- Published In:
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 28(7), 850-862 (2018)
- Authors:
- Colizzi, Marco(10), McGuire, Philip(21), Giampietro, Vincent(14), Williams, Steve, Brammer, Mick, Bhattacharyya, Sagnik
- Database ID:
- RTHC-01626
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Does even limited cannabis use change the brain permanently?
This study found lasting changes in cognitive brain function in people who had used cannabis only about 25 times in their lives, even during a period of abstinence. These "residual effects" included altered brain activation patterns during cognitive tasks.
Can tolerance to THC develop quickly?
Yes. Even about 25 lifetime cannabis exposures were sufficient to blunt the psychotomimetic and neurophysiological effects of acute THC in this study, demonstrating that some degree of tolerance develops rapidly.
Read More on RethinkTHC
- anger-irritability-quitting-weed-withdrawal
- appetite-after-quitting-weed
- caffeine-weed-withdrawal
- cannabinoid-hyperemesis-syndrome
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-perception-vs-evidence-gap
- cannabis-use-disorder-test
- cannabis-withdrawal-complete-guide
- cannabis-withdrawal-severity-levels-mild-moderate-severe
- cannabis-withdrawal-syndrome
- cannabis-withdrawal-syndrome-dsm-5
- cannabis-withdrawal-syndrome-timeline-day-by-day
- cannabis-withdrawal-vs-alcohol-nicotine-opioid-comparison
- cross-addiction-quit-weed-start-drinking
- emotional-after-quitting-weed-crying
- first-week-quitting-weed
- how-long-does-weed-withdrawal-last
- how-long-to-feel-normal-after-quitting-weed
- is-weed-addictive
- is-weed-addictive-science
- marijuana-withdrawal-symptoms
- night-sweats-quitting-weed-withdrawal
- paws-cannabis-post-acute-withdrawal
- quitting-weed-and-alcohol
- rehab-for-weed-addiction-necessary
- signs-of-cannabis-use-disorder
- weed-cravings
- weed-depersonalization-derealization
- weed-paws-withdrawal
- weed-vape-pen-addiction
- weed-withdrawal-anger
- weed-withdrawal-brain-fog
- weed-withdrawal-chest-tightness-heart-palpitations
- weed-withdrawal-crying-emotional
- weed-withdrawal-depression
- weed-withdrawal-headaches
- weed-withdrawal-irritability
- weed-withdrawal-men
- weed-withdrawal-mood-swings
- weed-withdrawal-nausea
- weed-withdrawal-night-sweats
- weed-withdrawal-no-appetite
- weed-withdrawal-sweating-detox
- weed-withdrawal-timeline
- weed-withdrawal-vs-alcohol
- weed-withdrawal-women
- what-happens-when-you-stop-smoking-weed
Cite This Study
https://rethinkthc.com/research/RTHC-01626APA
Colizzi, Marco; McGuire, Philip; Giampietro, Vincent; Williams, Steve; Brammer, Mick; Bhattacharyya, Sagnik. (2018). Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 28(7), 850-862. https://doi.org/10.1016/j.euroneuro.2018.04.003
MLA
Colizzi, Marco, et al. "Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2018. https://doi.org/10.1016/j.euroneuro.2018.04.003
RethinkTHC
RethinkTHC Research Database. "Modulation of acute effects of delta-9-tetrahydrocannabinol ..." RTHC-01626. Retrieved from https://rethinkthc.com/research/colizzi-2018-modulation-of-acute-effects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.